Rocket Lab USA (RKLB): Fundamental Analysis
Data sourced from SEC 10-K and 10-Q filings. Annual data through fiscal year ended December 31, 2025; most recent quarter ended March 31, 2026.
Snapshot & Big Picture
Rocket Lab USA is a vertically integrated space company offering small launch services (the Electron rocket), spacecraft manufacturing, and a growing suite of space systems components and services. The company is in an active investment phase — revenue has scaled dramatically from a small base, but the business remains pre-profitability as it funds launch cadence growth and the development of its larger Neutron rocket. The story here is one of rapid top-line expansion against a backdrop of persistent, though narrowing, operating losses.
Latest Quarter Snapshot (Q1 2026 — Most Current Data)
The quarter ended March 31, 2026 represents the most current financial picture available, more recent than the full-year 2025 annual figures.
| Metric | Q1 2026 |
|---|---|
| Revenue | $200.3M |
| Gross Margin | 38.2% |
| Operating Margin | -27.9% |
| Net Margin | -22.5% |
| EBITDA | -$41.0M |
| Current Ratio | 4.47x |
| Debt-to-Equity | 0.008x |
| Capital Expenditures | $27.1M |
| CapEx-to-Revenue | 13.5% |
Q1 2026 shows continued momentum: quarterly revenue of $200.3M implies an annualized run rate well above the full-year 2025 figure of $601.8M, suggesting the growth trajectory is accelerating into 2026. Gross margin reached 38.2% — the highest in the data set — and the operating loss margin of -27.9% is meaningfully better than the -38.0% posted for full-year 2025. The balance sheet looks healthy with a current ratio of 4.47x and nearly zero leverage (debt-to-equity of 0.008x).
Profitability — Multi-Year Trend
Rocket Lab has never been profitable on an operating or net basis, but the trajectory of margin improvement is clear and meaningful.
| Fiscal Year | Revenue | Gross Margin | Operating Margin | Net Margin | EBITDA |
|---|---|---|---|---|---|
| 2020 | $35.2M | -33.6% | -156.3% | -156.4% | -$45.6M |
| 2021 | $62.2M | -3.0% | -164.0% | -188.5% | -$91.2M |
| 2022 | $211.0M | 9.0% | -64.1% | -64.4% | -$105.3M |
| 2023 | $244.6M | 21.0% | -72.7% | -74.6% | -$148.2M |
| 2024 | $436.2M | 26.6% | -43.5% | -43.6% | -$156.1M |
| 2025 | $601.8M | 34.4% | -38.0% | -32.9% | -$184.9M |
Gross margin has improved from deeply negative (-33.6% in 2020) to a solid 34.4% in 2025, reflecting better manufacturing efficiency and a more favorable revenue mix as the space systems segment matures. Operating and net margins are still deeply negative, driven by heavy R&D and overhead investment, but they are clearly improving as revenue scales faster than fixed costs. EBITDA losses in dollar terms are still widening — from -$105M in 2022 to -$185M in 2025 — reflecting continued reinvestment rather than a loss of operating leverage. The Q1 2026 gross margin of 38.2% suggests 2026 could be a further step-change year on profitability.
Financial Health & Capital Expenditures
| Period | Current Ratio | Debt-to-Equity | Capital Expenditures | CapEx-to-Revenue |
|---|---|---|---|---|
| FY 2020 | 1.92x | 0.00x | $25.1M | 71.4% |
| FY 2021 | 8.04x | 0.14x | $25.7M | 41.3% |
| FY 2022 | 4.06x | 0.15x | $42.4M | 20.1% |
| FY 2023 | 2.13x | 0.19x | $54.7M | 22.4% |
| FY 2024 | 2.04x | 0.15x | $67.1M | 15.4% |
| FY 2025 | 4.08x | 0.001x | $156.3M | 26.0% |
| Q1 2026 | 4.47x | 0.008x | $27.1M | 13.5% |
Liquidity: The current ratio has expanded sharply from 2.04x in 2024 to 4.08x at year-end 2025 and further to 4.47x in Q1 2026, indicating Rocket Lab strengthened its cash position meaningfully — likely through equity raises. Debt-to-equity has effectively collapsed to near zero (0.001x at FY2025 end), making the balance sheet very conservatively leveraged.
Capital Intensity: CapEx jumped significantly in FY2025 to $156.3M (26.0% of revenue), up from $67.1M (15.4%) in FY2024. This step-up almost certainly reflects investment in Neutron rocket development and launch infrastructure. As a ratio of revenue, CapEx has trended down from its very high early-stage levels (71.4% in 2020) but ticked back up in 2025 due to this infrastructure build-out. The Q1 2026 CapEx-to-revenue ratio of 13.5% suggests the elevated spend rate may be moderating on a quarterly basis, but the business remains highly capital intensive and will continue to require substantial reinvestment for the foreseeable future as Neutron development progresses.
Growth
| CAGR Window | Start Year | End Year | Start Revenue | End Revenue | CAGR |
|---|---|---|---|---|---|
| 3-Year | FY 2022 | FY 2025 | $211.0M | $601.8M | 41.8% |
| 5-Year | FY 2020 | FY 2025 | $35.2M | $601.8M | 76.5% |
| 10-Year | N/A | N/A | N/A | N/A | Not available — Rocket Lab does not have 10 years of SEC filing history as a public company. |
A 3-year revenue CAGR of 41.8% and a 5-year CAGR of 76.5% (reflecting growth from a very small base) underscore that this has been one of the fastest-growing companies in the aerospace sector. Even setting aside the low base effect embedded in the 5-year figure, the 3-year CAGR from a more mature revenue base of $211M is impressive and suggests structural, not just statistical, momentum. With Q1 2026 revenue already at $200M in a single quarter, sustaining strong growth rates into 2026 appears well within reach.
Plain English Summary
Rocket Lab is a high-growth aerospace company that has scaled revenue at an extraordinary pace — from $35M in 2020 to over $600M in 2025 — while steadily improving its unit economics. The business is not yet profitable, and the dollar amount of its losses has actually grown as it invests heavily in infrastructure and Neutron rocket development. But the direction of margin improvement is consistent and encouraging: gross margin has gone from negative to nearly 40%, and operating losses as a percentage of revenue are shrinking each year. The balance sheet is in excellent shape with a strong cash cushion, minimal debt, and no signs of near-term liquidity stress. The main risks are the sustained cash burn, the large and uncertain capital requirements of Neutron, and execution risk inherent in launching a new rocket class. For investors, the core question is whether revenue can continue compounding fast enough — and margins can improve fast enough — to reach operating breakeven before the company needs to raise additional capital. The early 2026 data points are encouraging on both fronts.
Leave a Comment